Although adjustment for confounders attenuated these risks to some degree, increased odds of high grade and ER-negative tumours were observed in all ethnic minority groups and increased odds of high stage and Her2 positive were observed in the two black subgroups, compared to white women. The gene discussed is ERBB2; the disease is neoplasm.